[Plasmapheresis in the complex treatment of psoriatic arthritis].
Thirty-five psoriatic arthritis patients underwent combined treatment including plasmapheresis given in 3 sessions with a 7-day interval. Plasma elimination reached 500-600 ml per session. Additional polyglucin and saline administration was introduced to correct circulating plasma. Chemotherapy involved nonsteroid antiinflammatory drugs, cytostatics, corticosteroids. It is believed++ that plasmapheresis is a beneficial adjuvant to chemotherapy in psoriatic arthritis potentiating the drugs action and correcting immunity.
Milevskaia
S G
SG
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000628:therapy*; D003131:Combined Modality Therapy; D003911:Dextrans / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D013256:Steroids
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D003911:Dextrans; D013256:Steroids
Plazmaferez v kompleksnom lechenii psoriaticheskogo artrita.